Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
TWST Stock Chart & Stats
Day’s Range― - ―
52-Week Range$27.41 - $60.90
Previous CloseN/A
Volume152.02K
Average Volume (3M)872.43K
Market Cap
$2.79B
Enterprise Value$2.56B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta3.79
Next Earnings
May 01, 2025EPS Estimate
-0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.38
Shares Outstanding59,651,142
10 Day Avg. Volume1,027,460
30 Day Avg. Volume872,432
Standard Deviation0.21
R-Squared0.22
Alpha0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)8.79
Price to Cash Flow (P/CF)-32.50
P/FCF Ratio0.00
Enterprise Value/Market Cap0.92
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit19.21
Enterprise Value/Ebitda-14.49
Forecast
1Y Price Target
$54.29Price Target Upside20.43% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTwist Bioscience's low revenue exposure to China and limited exposure to US academic funding provides a competitive advantage.
Product InnovationTwist built a novel platform to industrialize DNA synthesis; this enables the increasingly rapid production of longer, customizable, and higher-quality DNA fragments that are 'written' onto a silicon chip.
Bears Say
Market ConditionsThere are questions around TWST's continued ability to take market share at current levels, given an uncertain sector backdrop.
---
Ownership Overview
3.17% Insiders
28.32% Mutual Funds
0.08% Other Institutional Investors
41.29% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $27.41 and its highest was $60.90 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Twist Bioscience Corp’s market cap is $2.79B.
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is May 01, 2025 which is in 69 days.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on Feb 03, 2025. The company reported -$0.53 earnings per share for the quarter, beating the consensus estimate of -$0.625 by $0.095.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Undervalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -0.55.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 59,651,142 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of -$0.53 in its last earnings report, beating expectations of -$0.625. Following the earnings report the stock price went up 0.726%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Currently, no hedge funds are holding shares in TWST
---
Twist Bioscience Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$54.29 (20.43% Upside)
$54.29 (20.43% Upside)
Blogger Sentiment
Bullish
TWST Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 237.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $156.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.3%
Last 30 Days ▲ 4.2%
Last 30 Days ▲ 4.2%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
17.33%
12-Months-Change
Fundamentals
Return on Equity
-43.28%
Trailing 12-Months
Asset Growth
-16.95%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.
---
TWST Company Deck
---
TWST Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong performance in revenue growth and gross margin improvement, driven by the SynBio and NGS segments. While there are challenges in the Biopharma segment and limited exposure to China, the company's strategic investments and innovative platform position it for future growth.Read More>---
TWST Stock 12 Month Forecast
Average Price Target
$54.29
▲(20.43% Upside)
Technical Analysis
Illumina
―
Editas Medicine
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Ginkgo Bioworks Holdings
―
Best Analysts Covering TWST
1 Year
1 Year Success Rate
19/30 ratings generated profit
1 Year Average Return
+25.62%
reiterated a buy rating 18 days ago
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 63.33% of your transactions generating a profit, with an average return of +25.62% per trade.
---